B
Beate Kempf-Bielack
Researcher at University of Münster
Publications - 15
Citations - 3821
Beate Kempf-Bielack is an academic researcher from University of Münster. The author has contributed to research in topics: Osteosarcoma & Sarcoma. The author has an hindex of 12, co-authored 15 publications receiving 3381 citations.
Papers
More filters
Journal ArticleDOI
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
Stefan S. Bielack,Beate Kempf-Bielack,Günter Delling,G. Ulrich Exner,Silke Flege,Knut Helmke,Rainer Kotz,Mechthild Salzer-Kuntschik,M. Werner,Winfried Winkelmann,Andreas Zoubek,Heribert Jürgens,Kurt Winkler +12 more
TL;DR: Axial tumor site, male sex, and a long history of symptoms were associated with poor response to chemotherapy in univariate and multivariate analysis.
Journal ArticleDOI
Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
Leo Kager,Andreas Zoubek,Ulrike Pötschger,Ulrike Kastner,Silke Flege,Beate Kempf-Bielack,Detlev Branscheid,Rainer Kotz,Mechthild Salzer-Kuntschik,Winfried Winkelmann,Gernot Jundt,Hartmut Kabisch,Peter Reichardt,Heribert Jürgens,Helmut Gadner,Stefan S. Bielack +15 more
TL;DR: The number of metastases at diagnosis and the completeness of surgical resection of all clinically detected tumor sites are of independent prognostic value in patients with proven primary metastatic osteosarcoma.
Journal ArticleDOI
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
Beate Kempf-Bielack,Stefan S. Bielack,Heribert Jürgens,Detlev Branscheid,Wolfgang E. Berdel,G. Ulrich Exner,Ulrich Göbel,Knut Helmke,Gernot Jundt,Hartmut Kabisch,Mathias Kevric,Thomas Klingebiel,Rainer Kotz,Rainer Maas,Rudolf Schwarz,Michael Semik,Jörn Treuner,Andreas Zoubek,Kurt Winkler +18 more
TL;DR: Time to relapse and tumor burden correlate with postrelapse outcome in osteosarcoma and Chemotherapy, particularly chemotherapy with more than one agent, may contribute to limited improvements in outcome.
Journal ArticleDOI
Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients
Stefan S. Bielack,Beate Kempf-Bielack,Detlev Branscheid,Dorothe Carrle,Godehard Friedel,Knut Helmke,Matthias Kevric,Gernot Jundt,Thomas Kühne,Rainer Maas,Rudolf Schwarz,Andreas Zoubek,Heribert Jürgens +12 more
TL;DR: This first report of survival estimates derived from large cohorts of unselected patients with second and subsequent osteosarcoma recurrences confirms the overwhelming importance of surgical clearance and prognosis indicators after rerecurrence resemble those known from first recurrence.
Journal ArticleDOI
Osteosarcoma over the age of forty.
Robert J. Grimer,Stephen R. Cannon,Antoni H. M. Taminiau,Stefan S. Bielack,Beate Kempf-Bielack,Reinhard Windhager,Martin Dominkus,Gunnar Sæter,Henrik C. F. Bauer,I Meller,M Szendroi,G. Follerås,Mikel San-Julian,J. W. Van Der Eijken +13 more
TL;DR: Osteosarcoma in the elderly is a curable condition and warrants intensive treatment with chemotherapy and surgical resection and it is found that older patients had less chemotherapy and fared worse.